An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Conventional therapies for glioblastoma multiforme (GBM) fail to target tumor cells exclusively, such that their efficacyis ultimately limited by nonspecific toxicity. Immunologic targeting of tumor-specific gene mutations, however, may allow more precise eradication of neoplastic cells. The epiderm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sampson, John H., Archer, Gary E., Mitchell, Duane A., Heimberger, Amy B., Herndon, James E., Lally-Goss, Denise, McGehee-Norman, Sharon, Paolino, Alison, Reardon, David A., Friedman, Allan H., Friedman, Henry S., Bigner, Darell D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2991139/
https://ncbi.nlm.nih.gov/pubmed/19825799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-09-0124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados